← Back to Clinical Trials
Recruiting NCT06229704

NCT06229704 Vestibular and Postural Function in Children Suspected of Balance Disorders

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06229704
Status Recruiting
Phase
Sponsor Gødstrup Hospital
Condition Children, Only
Study Type OBSERVATIONAL
Enrollment 30 participants
Start Date 2025-08-20
Primary Completion 2028-01

Eligibility & Interventions

Sex All sexes
Min Age 6 Months
Max Age 10 Years
Study Type OBSERVATIONAL
Interventions
video Head Impulse TestCervical Vestibular Evoked Myogenic PotentialOcular Vestibular Evoked Myogenic Potential

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 30 participants in total. It began in 2025-08-20 with a primary completion date of 2028-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this prospective cohort study is to investigate the vestibular function in children suspected of balance disorders, and to follow up on their balance progressions after rehabilitation. The main hypothesis of the study is that delayed gross motor development and symptoms of dizziness and balance problems in some children are caused by vestibular dysfunction. The investigators expect that early detection and rehabilitation by a physiotherapist will improve the balance ability for the child. The participants will be children in the age of 6 months to 10 years with delayed gross motor development and/or with dizziness/balance problems. The test protocol consists of questionnaires, hearing screening and vestibular and postural assessments.

Eligibility Criteria

Inclusion Criteria: * Children in the age of 6 months to 10 years * Delayed gross motor development and/or dizziness/balance problems. * Written informed consent from the parents. Exclusion Criteria: * Visual impairment to such a degree that the child is not able to maintain fixation on a dot one meter away. * Congenital nystagmus * Compromised eye muscle mobility * VEMP-electrode allergy * History of symptomatic head or neck trauma * Prescription of medicine which alters vestibular outputs (for instance sedative antihistamines)

Contact & Investigator

Central Contact

Signe F Bønløkke, PhD student

✉ siband@rm.dk

📞 +45 41405064

Principal Investigator

Therese Ovesen, Professor

STUDY CHAIR

University Clinic for Balance, Flavour and Sleep, Department of ENT, Gødstrup Hospital, DK

Frequently Asked Questions

Who can join the NCT06229704 clinical trial?

This trial is open to participants of all sexes, aged 6 Months or older, up to 10 Years, studying Children, Only. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06229704 currently recruiting?

Yes, NCT06229704 is actively recruiting participants. Contact the research team at siband@rm.dk for enrollment information.

Where is the NCT06229704 trial being conducted?

This trial is being conducted at Herning, Denmark.

Who is sponsoring the NCT06229704 clinical trial?

NCT06229704 is sponsored by Gødstrup Hospital. The principal investigator is Therese Ovesen, Professor at University Clinic for Balance, Flavour and Sleep, Department of ENT, Gødstrup Hospital, DK. The trial plans to enroll 30 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology